comparemela.com

Latest Breaking News On - Clinical trials office at weill cornell medicine - Page 1 : comparemela.com

Women have higher risk of death after coronary artery bypass surgery than men

Women are more likely than men to die after coronary artery bypass surgery, according to a large new study.

New yorkUnited statesMario gaudinoPresbyterian weill cornell medical centerClinical trials office at weill cornell medicineUs national heartBlood instituteWeill cornell medical centerJoint clinical trials officeWeill cornell medicineWeill cornell

Women Have Poorer Survival Than Men After Bypass Surgery

WEDNESDAY, March 8, 2023 (HealthDay News) Women are more likely than men to die after coronary artery bypass surgery, according to a large new study.

New yorkUnited statesMario gaudinoPresbyterian weill cornell medical centerClinical trials office at weill cornell medicineHealthday newsWeill cornell medical centerJoint clinical trials officeWeill cornell medicine

Study: Women have higher risk of dying after coronary artery bypass surgery than men

Compared with men, women continue to have a roughly 30-40 percent higher risk of dying following coronary artery bypass surgery, according to a large study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.

United statesWeill cornellMario gaudinoEmily hendersonPresbyterian weill cornell medical centerClinical trials office at weill cornell medicineSociety for thoracic surgeonsWeill cornell medicineWeill cornell medicalSuzanne weiss professorCardiothoracic surgeryWeill cornell medical centerAdult cardiac surgery databaseChicago based societyDiscovery industry focusJoint clinical trials office

Women face higher risk after coronary artery bypass surgery

Women face higher risk after coronary artery bypass surgery
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesWeill cornellJim schnabelMario gaudinoPresbyterian weill cornell medical centerClinical trials office at weill cornell medicineSociety for thoracic surgeonsWeill cornell medicineWeill cornell medicalSuzanne weiss professorCardiothoracic surgeryAdult cardiac surgery databaseChicago based societyJoint clinical trials office

Dual therapy offers both benefit and risk after common type of cardiac surgery

A new analysis shows that a combination of two anti-platelets drugs can benefit patients after the most common type of cardiac surgery -; while also increasing the risk of potentially dangerous bleeding.

Weill cornellMario gaudinoSigrid sandnerEmily hendersonPresbyterian weill cornell medical centerClinical trials office at weill cornell medicineWeill cornell graduate school of medical sciencesWeill cornell medicineSuzanne weiss professorCardiothoracic surgeryWeill cornell medicalWeill cornell graduate schoolMedical sciencesJoint clinical trials officeCardiac surgery

vimarsana © 2020. All Rights Reserved.